Abbott Laboratories 3Q Sales Top Expectations
The healthcare-products manufacturer logged earnings of $1.65 billion, or 94 cents a share, for the third quarter ended Sept. 30, up from $1.44 billion, or 82 cents a share, a year earlier. Adjusted earnings were $1.21 a share. Analysts polled by FactSet expected $1.20 a share.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...
Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results ...
TD Cowen analyst Josh Jennings maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...
(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates ...
Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was ...
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target ...
Abbott’s adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20. Also Read: Abbott ...
2d
Abbott Laboratories' Q3 earnings and topline growth largely expected to be in line with the Q2 trend. Find out whether ABT ...
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...
Abbott Laboratories ABT will release its quarterly earnings report on Wednesday, 2024-10-16. Here's a brief overview for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback